Vicore Pharma Holding AB (VCRE)
$9.00+2.04%Close
SELL
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.5B
- Beta
- 0.15
- P/E (TTM)
- -9.29
- Short % float
- 0.00%
- Days to cover
- 1.0
- SI change
- -57.0%
- 1W
- -3.54%
- 1M
- -21.81%
- vs SPY 1W
- -4.70%
- vs SPY 1M
- -24.80%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VCRE?
- LOPJLB’s latest quantitative signal on Vicore Pharma Holding AB (VCRE) is SELL. Signals are updated daily.
- What market regime is VCRE in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Vicore Pharma Holding AB (VCRE) do?
- Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.